By Jayla Burton, Program Manager
In our latest podcast episode, we break down what it means to build trust in science.
This episode covers the historical context of why certain communities don’t trust science, what is needed in order to start building trust, and who needs to be held accountable in this process.
Breast cancer science is continually evolving. Over the last few decades, there have been huge shifts in how we approach and treat this disease. For example, the development of immunotherapies and targeted therapies have given patients alternatives to surgical interventions and radical mastectomies. Additionally, researchers and practitioners are finally starting to acknowledge that breast cancer is influenced not only by individual behaviors and family history, but by environmental factors as well.
Though we have come a long way, there is still a long way to go to ensure treatments are safe, effective, and accessible. Patients are asked to “trust science,” but this cannot be done without science being trustworthy.Building trust is a long-term goal and can only be achieved through consistent truth-telling, honesty, listening, decentering of privilege, naming and addressing inequitable power dynamics, and so much more.
Trust in Science: A Panel Conversation offers the highlights of a conversation held at the 18th Annual Billie Gardner Loulan Memorial Benefit, with BCAction Executive Director Dr. Krystal Redman, BCAction Board Member Tamatha Thomas-Haase, and Tigerlily Founder and CEO Maimah Karmo. Together they discussed how our organizations can build a bridge between our community and science in an effort to begin building trust, while still holding science accountable.
We’re excited to bring you highlights from this panel conversation. Take a listen today!